Patients over 60 at increased risk of emergency cancer diagnosis
the ONA take:
According to a new study published in the journal BMJ Open, researchers have found that people over 60 years of age at an increased risk of being diagnosed with lung or colorectal cancer as an emergency in a hospital compared with younger people.
For the study, researchers analyzed data from over 20 studies that included more than 687,000 patients with colorectal or lung cancer.
Of those, more than 200,000 cases were diagnosed with cancer after an emergency hospital visit. Results showed than nearly 40% of of lung cancers and 25% of colorectal cancers in England were diagnosed during an emergency hospital visit between 2006 and 2010.
The findings suggest the importance to determine why some people are being diagnosed with cancer during an emergency admission.
Because survival chances are decreased in people diagnosed this way, further research is necessary to identify which patients are less likely to have their cancer diagnosed earlier, when patients have a better chance of survival.
People over 60 years of age at an increased risk of being diagnosed with lung or colorectal cancer as an emergency in a hospital.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows
- Replacing Neoadjuvant CRT with Multiagent Chemo Not Recommended for Rectal Cancer
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|